Demetrix Arete-G™, is CBG, a cannabinoid also known by its chemical name, cannabigerol, is made with our proprietary, sustainable method.
Author: Demetrix Admin
Manufacturing & Commercial Scale Up of CBG Our Rare Access interview this month month features Bart Haverkorn Van Rijsewijk. He is the Vice President of Manufacturing at Demetrix. In our conversation, we explore Demetrix commercial scale up, CMO partnerships, and much more. Click below to view the interview Would you mind letting everybody know your […]
After two years of virtual events, the Demetrix team recently traveled to in-Cosmetics Global in Paris, and Supply Side East in Secaucus, New Jersey. It was exciting to speak about the promise cannabinoids hold in the personal care and nutraceutical market with attendees. In-Cosmetics Global: A First for Demetrix Demetrix was a first-time exhibitor at […]
Partnership introduces bioactives to global beauty and personal care markets Berkeley, CA – Demetrix and German global specialty chemicals company Evonik, announce a supply agreement for cannabinoids to be used in beauty and personal care products. The first product, CBG (cannabigerol) will be entering the market in 2022. Coupling Demetrix’s proven production technology and Evonik’s leadership […]
Demetrix has initiated its 2022 commercial manufacturing campaign to support sales of cannabigerol (CBG). Initial global customers in the personal care and nutrition segments have agreed to purchase approximately 70% of our total production this year.
Rare bioactive ingredients like CBG are often touted for their benefits, but with limited data. We dig into the science and separate fact from fiction for this potent compound.